http://www.fda.gov/cder/orange/appendix_a.txt 400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE ECONOCHLOR, CHLORAMPHENICOL ECONOPRED PLUS, PREDNISOLONE ACETATE ECONOPRED, PREDNISOLONE ACETATE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDETATE DISODIUM, EDETATE DISODIUM EDEX, ALPROSTADIL EDROPHONIUM CHLORIDE PRESERVATIVE FREE, EDROPHONIUM...
FDA Drug Approvals List- October 1998 Drug Approvals for October 1998 Definitions and Notes October 1998 Original New Drug Applications Original Application #: 020926 Approval Date: 30-OCT-98 Trade Name: RENAGEL Chemical Type: 1 Therapeutic Potential: S Dosage Form: CAPSULE Applicant: GELTEX PHARMACEUTICALS INC Active Ingredient(s): SEVELAMER HYDROCHLORIDE OTC/RX Status: RX Indication(s): For the reduction of serum...
http://www.gpc-biotech.com/investoren/images/pdf2003/110603_Q3%20presentation_Analysten_Internet.pdf page 19
AP Ltr S-021.doc EMCYT may be poorly metabolized in patients wit liver function and s ould be administered wit in suc Because EMCYT may influence t e metabolism of calcium and p osp orus, it s ould be used wit in patients wit bone diseases t at are associated wit ypercalcemia or in patients wit insufficiencyEMCYT DES n= 93...
author: ATKINSB
AP Ltr S-021.doc page 1
author: ATKINSB
http://www.fda.gov/cder/ogd/rld/RLD_LABELING_APPROVED_OCT_1998.HTML Firm Date FLONASE Fluticasone propionate nasal spray 20-121 S-010 Glaxo Wellcome 1-Oct-1998 EMCYT Estramustine phosphate sodium capsules 18-045 S-010 Pharmacia and Upjohn 9-Oct-1998 COZAAR Losartan potassium tablets 20-386 S-008 Merck 13-Oct-1998 VASERETIC Enalapril maleate and HCTZ tablets 19-221 S-024 Merck 13-Oct-1998 TIMOLIDE Timolol maleate and HCTZ tablets 18-061 S...
Cancer Care Ontario Formulary Information for patients, health professionals and public on cancer prevention, screening, treatment (radiation, chemotherapy, surgery), supportive care, research, education, and standards and guidelines ...
http://www.anormed.com/documents/ff_HRPC.pdf Emcyt (Estramustine phosphate) – Pharmacia Approved Indication: Emcyt capsules are indicated in the palliative treatment of patients with metastatic and/ or progressive carcinoma of the prostateEmcyt vs
http://www.anormed.com/documents/ff_HRPC.pdf page 2
http://www.cancercare.on.ca/formulary/pdfmedicationinfo/Estramustine.pdf For more information on this medication, please call your doctor or nurse, or the Cancer Centre Drug Information pharmacist. MEDICATION INFO SHEET ESTRAMUSTINE (ess- tra- MUSS- teen) Other Names for this Medication: Emcyt (Brand Name) Appearance: White capsules containing 140mg Estramustine. ...
http://www.cancercare.on.ca/formulary/pdfmedicationinfo/Estramustine.pdf page 1 For more information on this medication, please call your doctor or nurse, or the Cancer Centre Drug Information pharmacist. MEDICATION INFO SHEET ESTRAMUSTINE (ess- tra- MUSS- teen) Other Names for this Medication: Emcyt (Brand Name) Appearance: White capsules containing 140mg Estramustine. ...
http://www.cancercare.on.ca/formulary/pdfdrugs/ESTRAMUS.pdf Estramustine CCO Formulary Revised March 2000 A DRUG NAME: ESTRAMUSTINE SYNONYM( S): Estramustine sodium phosphate COMMON TRADE NAME( S): Emcyt® (Pharmacia & Upjohn) B MECHANISM OF ACTION AND PHARMACOKINETICS Estramustine phosphate is a combination of estradiol with nornitrogen mustard. ...
http://www.cancercare.on.ca/formulary/pdfdrugs/ESTRAMUS.pdf page 1 Estramustine CCO Formulary Revised March 2000 A DRUG NAME: ESTRAMUSTINE SYNONYM( S): Estramustine sodium phosphate COMMON TRADE NAME( S): Emcyt® (Pharmacia & Upjohn) B MECHANISM OF ACTION AND PHARMACOKINETICS Estramustine phosphate is a combination of estradiol with nornitrogen mustard. ...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt IN HYOGO, JAPAN" 6254 01-Apr-86 HOVIONE SOCIEDADE QUIMICA LDA "BECLOMETHASONE 17,21-DIPROPIONATE" 6258 27-Mar-86 PHARMACIA AND UPJOHN INC "ESTRAMUSTINE PHOSPHATE SODIUM AS MFG
http://www.fda.gov/cder/dmf/xls/4Q2003ACTIVETYPE2EXCEL.xls AVENTIS PHARMA SA HYDROCORTISONE HEMISUCCINATE ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV ERTHROMYCIN PHOSPHATE ORGAMOL SA BUPIVACAINE HCL AVENTIS PHARMA SA 6-ALPHA-METHYLPREDNISOLONE HEMISUCCINATE PROCOS SPA PHENYLTOLOXAMINE CITRATE PROCOS SPA ORPHENADRINE HYROCHLORIDE & ORPHENADRINE CITRATE BASF CORP POVIDONE-IODINE LEK PHARMACEUTICALS D.D
Contents Vol. 2, No. 5, 2003 5, 2003 Contents Leading Articles Chronic Myeloid Leukemia: The Value of Tyrosine Kinase 305- 311 Inhibition TI Mughal, JM Goldman Oncolytic Viruses for Cancer Therapy 313- 323 M Gromeier Therapy In Practice Management of Testicular Germ Cell Tumors 325- 334 RA Huddart, DP Dearnaley, A Horwich Review Article Promising New Approaches in the Treatment of Advanced Head 335- 347 and Neck...
author: Adis International Limited
subject: American Journal of Cancer
Lovelace Respiratory Research Institute - Directory of Scientists Directory of Scientists Management 2003 Board of Directors Research Program Oversight Committee - MOSELEY, POPE L., MD - CONTACT INFORMATION Fax: (505) 272-8700 e-mail: pmoseley@salud.unm.edu 1/03 EDUCATION B.S
